IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Strahlentherapie und Onkologie (Print)

• Publication date

  2016-02-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s00066-015-0900-9PMID 26438071
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of patient reported symptom burden in patients with ovarian cancer undergoing primary vs. interval tumor reductive surgery.

  2017cited by this paper
• Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.

  2015cited by this paper
• Clinical Investigation : Thoracic Cancer A Population-Based Comparative Effectiveness Study of Radiation Therapy Techniques in Stage III Non-Small Cell Lung Cancer

  2014cited by this paper
• Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: predictors of use and association with toxicities.

  2013cited by this paper
• Treatment outcome and toxicity of intensity-modulated (chemo) radiotherapy in stage III non-small cell lung cancer patients

  2012cited by this paper
• Intensity-modulated radiotherapy in the treatment of breast cancer.

  2012cited by this paper
• Intensity-modulated radiotherapy in the treatment of lung cancer.

  2012cited by this paper
• High-dose radiotherapy in inoperable nonsmall cell lung cancer: comparison of volumetric modulated arc therapy, dynamic IMRT and 3D conformal radiotherapy.

  2012cited by this paper
• Does VMAT for treatment of NSCLC patients increase the risk of pneumonitis compared to IMRT ? – A planning study

  2012cited by this paper
• Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.

  2011cited by this paper
• Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity‐modulated RT radiotherapy and cetuximab

  2011cited by this paper
• F-18-FDG-PET confined radiotherapy of locally advanced NSCLC with concomitant chemotherapy: results of the PET-PLAN pilot trial.

  2011cited by this paper
• Radiation dose-volume effects in the esophagus.

  2010cited by this paper
• Radiation dose-volume effects in the lung.

  2010cited by this paper
• European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer.

  2010cited by this paper
• Radiation dose-volume effects in the brain.

  2010cited by this paper
• Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy.

  2010cited by this paper
• Radiation dose-volume effects in the heart.

  2010cited by this paper
• Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer

  2009cited by this paper
• A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515.

  2009cited by this paper
• Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: non-small-Cell lung cancer (NSCLC).

  2008cited by this paper
• A Randomized Study of Involved-Field Irradiation Versus Elective Nodal Irradiation in Combination With Concurrent Chemotherapy for Inoperable Stage III Nonsmall Cell Lung Cancer

  2007cited by this paper
• Involved-field radiation therapy for inoperable non small-cell lung cancer.

  2007cited by this paper
• CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan.

  2005cited by this paper
• Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.

  2005cited by this paper
• Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study.

  2005cited by this paper
• Influence of intra-fractional breathing movement in step-and-shoot IMRT.

  2004cited by this paper
• Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.

  2004cited by this paper
• Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.

  2003cited by this paper
• Effects of intra-fraction motion on IMRT dose delivery: statistical analysis and simulation.

  2002cited by this paper
• Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients.

  1999cited by this paper
• A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy.

  1998cited by this paper
• Tumour and normal tissue responses to fractionated non-uniform dose delivery.

  1992cited by this paper
• Open Access Research

  year unknowncited by this paper

• Learning curve of lung dose optimization in intensity‐modulated radiotherapy for locally advanced non‐small cell lung cancer

  2023cites this paper
• High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodes

  2023cites this paper
• [Dosimetric and toxicity comparison of IMRT and 3D-CRT of non-small cell lung cancer].

  2021cites this paper
• Feasibility of intensity modulated radiotherapy with involved field radiotherapy for Japanese patients with locally advanced non-small cell lung cancer

  2021cites this paper
• Zielvolumenreduktion durch 18F-FDG-PET/CT-basierte „involved field“ Bestrahlung beim fortgeschrittenen NSCLC möglicherweise neuer Standard: Ergebnisse der PET-Plan-Studie

  2020cites this paper
• Comparison of Involved Field Radiotherapy versus Elective Nodal Irradiation in Stage IIIB/C Non-Small-Cell Lung Carcinoma Patients Treated with Concurrent Chemoradiotherapy: A Propensity Score Matching Study

  2020cites this paper
• A meta-analysis

  2020cites this paper
• 18F-FDG-PET-basierte ZV-Planung effektiv?

  2020cites this paper
• Protective effects of phenformin on zebrafish embryonic neurodevelopmental toxicity induced by X-ray radiation

  2019cites this paper
• Effects of respiratory motion on volumetric and positional difference of GTV in lung cancer based on 3DCT and 4DCT scanning

  2018cites this paper
• Radiotherapy for extramedullary leukaemic manifestation (Chloroma)

  2018cites this paper
• Early tumor shrinkage served as a prognostic factor for patients with stage III non-small cell lung cancer treated with concurrent chemoradiotherapy

  2018cites this paper
• Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer

  2017cites this paper
• Dosimetric predictors of radiation-induced pericardial effusion in esophageal cancer

  2017cites this paper
• The Impact of Diffusion-Weighted MRI on the Definition of Gross Tumor Volume in Radiotherapy of Non-Small-Cell Lung Cancer

  2016cites this paper
• Involved field radiotherapy (IFRT) versus elective nodal irradiation (ENI) for locally advanced non-small cell lung cancer: a meta-analysis of incidence of elective nodal failure (ENF)

  2016cites this paper